Key Financial Data First half / second quarter 2010
Strong improvement in operating business - Outlook for 2010 raised again
- Record EBITDA and EBIT
- Considerable improvement in net income
- Further rise in cash flow
- Outlook for 2010: significant rise in sales, EBITDA and EBIT expected
"Following a strong start to the year, there has been a further clear improvement in our operating business," commented Klaus Engel, Chairman of the Executive Board of Evonik Industries AG, today, when the company published its key financial data for the first half and second quarter of 2010. The Group's operating results were above the level reported in 2008, before the economic crisis. "That is an impressive hike in earnings in the wake of the crisis. We are on course for growth," said Engel. "For example, the MATCH production complex for highperformance plastics, which came on stream in Shanghai at the end of last year, is operating at full capacity," he reported. The successful startup of additional capacity is enabling Evonik to benefit from global growth. Although a slight slowdown in the economic upswing is anticipated in the second half of this year, Engel is upbeat: "In view of the good business trend we are far more optimistic about the outlook for the year as a whole than we were at the start of the year and have raised our forecast again."
The Evonik Group grew sales 24 percent to €7,799 million in the first six months of 2010 (H1 2009: €6,281 million), principally due to a sharp rise in demand. EBITDA (earnings before interest, taxes, depreciation and amortization) surged 83 percent to €1,532 million in the first half of 2010 (H1 2009: €839 million) and the EBITDA margin was 19.6 percent, well above the prior year level of 13.4 percent. EBIT (earnings before interest and taxes) increased by 159 percent to €1,148 million (H1 2009: €443 million), driven mainly by the pleasing development of the Chemicals and Energy Business Areas.
The non-operating loss of €143 million mainly comprises expenses for pensions in the UK and for the On Track efficiency enhancement program. Income before income taxes from the continuing operations was €756 million, an increase of €601 million (388 percent) compared with the first half of 2009. Overall, the Evonik Group's net income was €530 million, considerably higher than at the end of the first six months of 2009 (€43 million).
Thanks to the clear increase in the operating result, the Group was able to raise the cash flow from operating activities by €101 million to €910 million in the first half of 2010, despite a rise in net working capital resulting from the perceptible upturn in business. Capital expenditures amounted to €288 million. In Nanning (China) Evonik started up a new production facility for pharmaceutical active ingredients. At the facility in Shanghai (China), production capacity for methacrylic acid was increased to 25,000 metric tons p.a. in response to high demand from the coatings and colorants sector. In addition, a new production facility for precious metal powder catalysts for pharmaceuticals, fine and industrial chemicals came into service. Evonik was able to finance both capital expenditures and the €320 million dividend payment for fiscal 2009 out of the cash flow. Despite this, net financial debt was €3,495 million, virtually unchanged from yearend 2009 (€3,431 million). It has been reduced by €1,088 million since year end 2008.
Considerable improvement in the Group's Q2 results
The Evonik Group benefited from high demand and rising prices in the second quarter of 2010, enabling it to achieve a further improvement in both sales and the operating result compared with the first quarter. The results were also well above the prior year figures, which were severely impacted by the economic crisis.
Group sales increased to €4,030 million, a rise of 31 percent yearonyear (Q2 2009: €3,076 million). EBITDA climbed 55 percent to €788 million (Q2 2009: €510 million). Thanks to the good business trend, EBIT increased 87 percent in the second quarter to €594 million (Q2 2009: €317 million). Overall, net income rose 170 percent to €240 million (Q2 2009: €89 million).
Positive development in all three business areas
All three business areas reported a very successful operating performance in the first six months of 2010.
The Chemicals Business Area registered substantial volume growth in Asia, while demand picked up perceptibly in Europe and slightly in North America. Overall, sales advanced 34 percent to €6,275 million in the first half of 2010 (H1 2009: €4,673 million), driven by increased volumes (25 percentage points) and higher selling prices (7 percentage points). Currency effects and changes in the scope of consolidation each contributed 1 percentage point to the rise. EBITDA climbed 91 percent to €1,236 million (H1 2009: €648 million). EBIT improved 180 percent to €925 million (H1 2009: €330 million), principally due to a strong rise in demand and the related improvement in capacity utilization. So far, the clear rise in raw material costs has been offset largely by raising selling prices.
In the Energy Business Area sales were almost unchanged yearonyear at €1,323 million (H1 2009: €1,339 million). EBITDA rose 57 percent to €281 million (H1 2009: €179 million), while EBIT was 80 percent higher at €240 million (H1 2009: €133 million). This was mainly due to coal trading, which had been held back by oneoff factors in the first half of 2009. Moreover, power plants in Germany registered higher demand for electricity in the wake of the economic recovery.
Sales contracted by 3 percent to €178 million in the Real Estate Business Area in the first half of 2010 (H1 2009: €184 million). EBITDA climbed 8 percent to €91 million (H1 2009: €84 million). EBIT was €67 million, €4 million above the yearback level, mainly because of the good performance by property management.
On Track efficiency program remains important
Good progress is still being made with the On Track efficiency enhancement program, which bundles all activities geared to achieving a sustained improvement in Evonik's competitiveness. This program includes reviewing of all major cost positions in the Group and analyzing structures and processes. The aim is to achieve sustained costsavings of €500 million p.a. from 2012. "We will continue to drive this program forward systematically to secure a good competitive position for the future," stressed Engel.
Outlook for 2010 raised again
The economy developed well in the first half of 2010. However, the economic upswing is expected to slow somewhat in the second half of the year. Nevertheless, slight growth in the global economy is expected over the year as a whole.
Following its successful performance in the first six months, Evonik is far more optimistic about the outlook for the year as a whole than it was at the start of the year, although the improvement could be dampened by the continued significant rise in raw material costs. Thanks to far higher demand, the Group now anticipates that sales growth will be in the doubledigit percentage range this year. Overall, both EBITDA and EBIT are expected to be far higher than last year.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
Evonik Industries AG
business of specialty chemicals, we are a global leader. In addition, Evonik is an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our company's performance is shaped by creativity, specialization, continuous selfrenewal, and reliability.
Evonik is active in over 100 countries around the world. In its fiscal year 2009 about 39,000 employees generated sales of about €13.1 billion and an operating profit (EBITDA) of about €2.0 billion.